Rockwell Medical (RMTI) Invested Capital (2013 - 2026)

Rockwell Medical's Invested Capital history runs 11 years deep, the most recent figure standing at $658000.0 for Q1 2026.

• Quarterly Invested Capital fell 52.46% year-over-year to $658000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 44.5% YoY) and the FY2025 annual result came in at $773000.0, down 49.48% from the prior year.
• Invested Capital was $658000.0 for Q1 2026 at Rockwell Medical, down from $773000.0 in the prior quarter.
• Across five years, Invested Capital topped out at $3.0 million in Q1 2022 and bottomed at $658000.0 in Q1 2026.
• A 5-year average of $1.8 million and a median of $1.8 million in 2024 frame the typical range for Invested Capital.
• Peak annual rise in Invested Capital reached 122.36% in 2022, while the deepest fall reached 77.9% in 2022.
• Rockwell Medical's Invested Capital stood at $1.6 million in 2022, then climbed by 28.02% to $2.1 million in 2023, then dropped by 26.72% to $1.5 million in 2024, then tumbled by 49.48% to $773000.0 in 2025, then declined by 14.88% to $658000.0 in 2026.
• Business Quant data shows RMTI's Invested Capital at $658000.0 in Q1 2026, $773000.0 in Q4 2025, and $884000.0 in Q3 2025.